BIOPTIMUS
DEAD

Serial Number

98351159

Owner

BIOPTIMUS

Attorney

Andrew D. Bochner

Filing Date

Jan 10, 2024

Add to watchlist:

No watchlists yet
View on USPTO

BIOPTIMUS Trademark

Serial Number: 98351159

BIOPTIMUS is a trademark filed by BIOPTIMUS on January 10, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

BIOPTIMUS (6 trademarks)

14-16 Boulevard Poissonnière
Paris F-75009 , FR

Entity Type: 99

Trademark Details

Filing Date

January 10, 2024

Registration Date

Not Registered

Goods & Services

Downloadable software using artificial intelligence and machine learning for performing and recording research, and for performing diagnostic tests in the fields of biology, pharmacology, bioengineering and life sciences; Downloadable software using artificial intelligence for performing and recording research, and for performing diagnostic tests in the fields of biology, pharmacology, bioengineering and life sciences specifically related to healthcare; Downloadable computer software and programs using artificial intelligence for data and software processing, data generation, and for understanding and analyzing that data; downloadable computer programs and downloadable computer software using artificial intelligence for developing, running and analyzing algorithms that are able to learn to analyze, classify, and take actions in response to exposure to data; downloadable computer software for use in simulation environments for the purpose of testing artificial intelligence agents, algorithms and programs; downloadable computer software and programs for diagnosing health conditions, prescribing treatments and writing prescriptions, designing clinical tests and forecasting clinical test results, searching for clinical trial participants, analysing medical images, analysing data, and developing pharmaceuticals and chemical compounds

Software as a service (SAAS) services featuring software using artificial intelligence for performing and recording research, and for performing diagnostic tests in the fields of biology, pharmacology, bioengineering and life sciences; Research in the field of artificial intelligence technology; technology consulting in the field of artificial intelligence; Software as a service (SaaS) services featuring software for diagnosing health conditions, prescribing treatments and writing prescriptions, designing clinical tests and forecasting clinical test results, searching for clinical trial participants, analyzing medical images, analyzing data, and developing pharmaceuticals and chemical compounds; Scientific and technological services, namely, research in the fields of biotechnology, drug discovery and development, and diagnostic preparations; Advisory services relating to scientific research; Scientific research; Engineering services; Technical consultancy services relating to computer programming; Research and development services in the field of engineering; Development of computer programs; Software design and development

Filing History

ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Jul 16, 2025 MAB3
ABANDONMENT - AFTER EX PARTE APPEAL
Jul 16, 2025 ABN3
EXPARTE APPEAL TERMINATED
Jul 16, 2025 EXPT
EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Jun 5, 2025 EXFB
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Feb 21, 2025 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Feb 21, 2025 GECD
ACTION CONTINUING FINAL - COMPLETED
Feb 21, 2025 CNCF
EX PARTE APPEAL-INSTITUTED
Feb 20, 2025 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Feb 20, 2025 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Feb 20, 2025 EXAF
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 19, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 19, 2024 GNFN
FINAL REFUSAL E-MAILED
Nov 19, 2024 GNFR
FINAL REFUSAL WRITTEN
Nov 19, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 6, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 6, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 6, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 6, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 6, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 30, 2024 NWOS
NEW APPLICATION ENTERED
Jan 10, 2024 NWAP